1. Home
  2. VIRX vs SCKT Comparison

VIRX vs SCKT Comparison

Compare VIRX & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIRX
  • SCKT
  • Stock Information
  • Founded
  • VIRX 2007
  • SCKT 1992
  • Country
  • VIRX United States
  • SCKT United States
  • Employees
  • VIRX N/A
  • SCKT N/A
  • Industry
  • VIRX Biotechnology: Pharmaceutical Preparations
  • SCKT Computer Manufacturing
  • Sector
  • VIRX Health Care
  • SCKT Technology
  • Exchange
  • VIRX Nasdaq
  • SCKT Nasdaq
  • Market Cap
  • VIRX 7.7M
  • SCKT 9.0M
  • IPO Year
  • VIRX N/A
  • SCKT 1995
  • Fundamental
  • Price
  • VIRX $0.16
  • SCKT $1.47
  • Analyst Decision
  • VIRX Buy
  • SCKT
  • Analyst Count
  • VIRX 4
  • SCKT 0
  • Target Price
  • VIRX $5.00
  • SCKT N/A
  • AVG Volume (30 Days)
  • VIRX 2.5M
  • SCKT 39.0K
  • Earning Date
  • VIRX 11-13-2024
  • SCKT 10-24-2024
  • Dividend Yield
  • VIRX N/A
  • SCKT N/A
  • EPS Growth
  • VIRX N/A
  • SCKT N/A
  • EPS
  • VIRX N/A
  • SCKT N/A
  • Revenue
  • VIRX N/A
  • SCKT $18,329,896.00
  • Revenue This Year
  • VIRX N/A
  • SCKT $10.78
  • Revenue Next Year
  • VIRX N/A
  • SCKT $8.00
  • P/E Ratio
  • VIRX N/A
  • SCKT N/A
  • Revenue Growth
  • VIRX N/A
  • SCKT 2.94
  • 52 Week Low
  • VIRX $0.13
  • SCKT $0.91
  • 52 Week High
  • VIRX $1.31
  • SCKT $1.53
  • Technical
  • Relative Strength Index (RSI)
  • VIRX 32.53
  • SCKT 72.27
  • Support Level
  • VIRX $0.14
  • SCKT $1.24
  • Resistance Level
  • VIRX $0.21
  • SCKT $1.50
  • Average True Range (ATR)
  • VIRX 0.01
  • SCKT 0.08
  • MACD
  • VIRX -0.00
  • SCKT 0.03
  • Stochastic Oscillator
  • VIRX 43.86
  • SCKT 92.31

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, out of which the majority of the revenue is generated from the United States.

Share on Social Networks: